Everest Organics Limited has successfully completed its postal ballot process, with all three special resolutions receiving overwhelming shareholder approval of 99.99%. The pharmaceutical company declared the results on December 17, 2025, following the conclusion of remote e-voting on December 16, 2025.

Postal Ballot Overview

The postal ballot was conducted under Section 110 of the Companies Act, 2013, with the notice dated November 12, 2025. Y. Ravi Prasada Reddy (Membership No. FCS5783), Proprietor of RPR Associates, served as the appointed scrutinizer for the remote e-voting process. The company had 8,047 total shareholders on the record date of November 14, 2025.

Resolution Results

All three special resolutions were passed with remarkable shareholder support, achieving 99.99% approval rates. The voting results demonstrate strong confidence in the company's leadership decisions and board restructuring initiatives.

Resolution 1: Director Appointment

Appointment and remuneration payable to Mr. Venkata Satya Subbarao Pachigolla (DIN: 08363668) as Whole-Time Director (Executive Director) effective November 12, 2025.

Resolution 2: Independent Director Designation

Change in designation of Mr. Kirankumar Rampally (DIN: 07621817) from Non-Executive Non-Independent to Non-Executive Independent Director effective November 12, 2025.

Resolution 3: Director Designation Change

Change in designation of Mr. Prasad Venkata Satya Sundara Srikakolapu (DIN: 08304477) from Non-Executive Independent Director to Non-Executive Non-Independent Director effective November 12, 2025.

Detailed Voting Statistics

The postal ballot witnessed participation from 40 members who exercised their voting rights through remote e-voting. All resolutions received identical voting patterns with overwhelming support from shareholders across all categories.

Company Information

Everest Organics Limited operates as an ISO 9001:2015 and WHO GMP certified pharmaceutical company. The company maintains its corporate office at Dwaraka Heights, Jubilee Enclave, Madhapur, Hyderabad, with manufacturing facilities at Aroor Village, Sadasivpet Mandal, Sangareddy District, Telangana. Company Secretary Shweta Singh signed the compliance document confirming the successful completion of the postal ballot process and submitted the results to BSE Limited.

Everest Organics Limited , a pharmaceutical company, has issued a postal ballot notice to seek shareholder approval for three special resolutions aimed at restructuring its board of directors. The company is proposing significant changes in its leadership structure, including new appointments and changes in designations.

Key Proposals

1. Appointment of New Whole-Time Director: The company proposes to appoint Mr. Venkata Satya Subbarao Pachigolla as a Whole-Time Director, designated as Executive Director. If approved, Mr. Pachigolla will serve for a term of three years, from November 12, 2025, to November 11, 2028, with a monthly remuneration of Rs. 2,00,000.

2. Change in Designation - Non-Executive to Independent Director: The board seeks to redesignate Mr. Kirankumar Rampally from Non-Executive Non-Independent Director to Non-Executive Independent Director, effective November 12, 2025.

3. Change in Designation - Independent to Non-Independent Director: The company proposes to change the designation of Mr. Prasad Venkata Satya Sundara Srikakolapu from Non-Executive Independent Director to Non-Executive Non-Independent Director, also effective from November 12, 2025.

Voting Process

Everest Organics has set up a remote e-voting process for shareholders to cast their votes on these resolutions. The voting period is scheduled as follows:

Director Profiles

Mr. Venkata Satya Subbarao Pachigolla

• Age: 52 years
• Qualification: Master of Computer Applications from Osmania University
• Experience: Over 25 years in information technology, analytics, and business solutions
• Current Role: Founder & CEO of WebRocket Pvt. Ltd.

Mr. Kirankumar Rampally

• Age: 63 years
• Qualification: M. Tech (Chemical Engineering)
• Experience: 36 years in various organizations, including roles as COO and President in pharmaceutical and biotechnology companies

Mr. Prasad Venkata Satya Sundara Srikakolapu

• Age: 63 years
• Qualification: M. Com., DBM & CAIIB
• Experience: Around 30 years in the Banking Sector, retired as Chief General Manager from Union Bank of India

These proposed changes reflect Everest Organics' efforts to strengthen its board with diverse expertise in technology, pharmaceuticals, and finance. Shareholders are encouraged to review the detailed postal ballot notice and cast their votes before the deadline.